<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maas RPPWM</submitter><funding>Medical Research Council Canada</funding><funding>Fundação para a Ciência e a Tecnologia</funding><funding>Bundesministerium für Bildung und Forschung</funding><funding>EU Joint Programme – Neurodegenerative Disease Research</funding><funding>National Ataxia Foundation</funding><funding>Medical Research Council</funding><funding>Fundo Regional para a Ciência e Tecnologia</funding><pagination>1850-1860</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9540189</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Disease severity in spinocerebellar ataxia type 3 (SCA3) is commonly defined by the Scale for the Assessment and Rating of Ataxia (SARA) sum score, but little is known about the contributions and progression patterns of individual items.&lt;h4>Objectives&lt;/h4>To investigate the temporal dynamics of SARA item scores in SCA3 patients and evaluate if clinical and demographic factors are differentially associated with evolution of axial and appendicular ataxia.&lt;h4>Methods&lt;/h4>In a prospective, multinational cohort study involving 11 European and 2 US sites, SARA scores were determined longitudinally in 223 SCA3 patients with a follow-up assessment after 1 year.&lt;h4>Results&lt;/h4>An increase in SARA score from 10 to 20 points was mainly driven by axial and speech items, with a marke</pubmed_abstract><journal>Movement disorders : official journal of the Movement Disorder Society</journal><pubmed_title>Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3.</pubmed_title><pmcid>PMC9540189</pmcid><funding_grant_id>01ED1602A/B</funding_grant_id><pubmed_authors>Klockgether T</pubmed_authors><pubmed_authors>Pires P</pubmed_authors><pubmed_authors>Infante J</pubmed_authors><pubmed_authors>Afonso Ribeiro J</pubmed_authors><pubmed_authors>van Gaalen J</pubmed_authors><pubmed_authors>Maas RPPWM</pubmed_authors><pubmed_authors>Bushara K</pubmed_authors><pubmed_authors>Giunti P</pubmed_authors><pubmed_authors>Faber J</pubmed_authors><pubmed_authors>Timmann D</pubmed_authors><pubmed_authors>van de Warrenburg BPC</pubmed_authors><pubmed_authors>Onyike C</pubmed_authors><pubmed_authors>Santana MM</pubmed_authors><pubmed_authors>Lima M</pubmed_authors><pubmed_authors>Hubener-Schmid J</pubmed_authors><pubmed_authors>Synofzik M</pubmed_authors><pubmed_authors>Garcia-Moreno H</pubmed_authors><pubmed_authors>Teerenstra S</pubmed_authors><pubmed_authors>Schols L</pubmed_authors><pubmed_authors>Pereira de Almeida L</pubmed_authors><pubmed_authors>Reetz K</pubmed_authors><pubmed_authors>de Vries JJ</pubmed_authors><pubmed_authors>Jacobi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3.</name><description>&lt;h4>Background&lt;/h4>Disease severity in spinocerebellar ataxia type 3 (SCA3) is commonly defined by the Scale for the Assessment and Rating of Ataxia (SARA) sum score, but little is known about the contributions and progression patterns of individual items.&lt;h4>Objectives&lt;/h4>To investigate the temporal dynamics of SARA item scores in SCA3 patients and evaluate if clinical and demographic factors are differentially associated with evolution of axial and appendicular ataxia.&lt;h4>Methods&lt;/h4>In a prospective, multinational cohort study involving 11 European and 2 US sites, SARA scores were determined longitudinally in 223 SCA3 patients with a follow-up assessment after 1 year.&lt;h4>Results&lt;/h4>An increase in SARA score from 10 to 20 points was mainly driven by axial and speech items, with a marke</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-22T02:00:44.497Z</modification><creation>2025-04-05T20:11:24.308Z</creation></dates><accession>S-EPMC9540189</accession><cross_references><pubmed>35808813</pubmed><doi>10.1002/mds.29135</doi></cross_references></HashMap>